If you caught NCPA CEO Douglas Hoey’s Executive Update last Friday, you read about Danny Cottrell’s perspective on the event. "I've always thought [fly-in] was the most important meeting they could possibly go to," he told America's Pharmacist® in a profile last summer.
Resources Top 4: Lithium gun PMT s board plays musical chairs in Quebec; NGX up on African graphite stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.
The Federal Trade Commission is scheduled to vote today on whether or not to reverse course on prior statements that opposed mandatory PBM transparency and disclosure requirements. The vote, if successful, will effectively remove a major line of defense for PBMs that promote one-sided business relationships, stifle competition and reduce patient choice. NCPA’s General Counsel, Matt Seiler, submitted oral comments to the commissioners encouraging them to vote yes on the matter.